1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. US Home Diagnostics for Urinary Tract Infection Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. US Home Diagnostics for Urinary Tract Infection Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Increasing Prevelance of UTI
5.2 Market Opportunities
- 5.2.1 Encouragement for Home Diagnostics
5.3 Future Trends
- 5.3.1 Development of innovative products with advanced computing technologies for urine diagnostics
5.4 Impact of Drivers and Restraints
6. US Home Diagnostics for Urinary Tract Infection Market Regional Analysis
6.1 US Home Diagnostics for Urinary Tract Infection Market Overview
6.2 US Home Diagnostics for Urinary Tract Infection Market Revenue 2017-2027 (US$ Million)
6.3 US Home Diagnostics for Urinary Tract Infection Market Forecast Analysis
7. US Home Diagnostics for Urinary Tract Infection Market Analysis – by Form Type
7.1 Dipsticks
- 7.1.1 Overview
- 7.1.2 Dipsticks: US Home Diagnostics for Urinary Tract Infection Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Cups
- 7.2.1 Overview
- 7.2.2 Cups: US Home Diagnostics for Urinary Tract Infection Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Dipslides
- 7.3.1 Overview
- 7.3.2 Dipslides: US Home Diagnostics for Urinary Tract Infection Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Cassettes
- 7.4.1 Overview
- 7.4.2 Cassettes: US Home Diagnostics for Urinary Tract Infection Market – Revenue and Forecast to 2031 (US$ Million)
8. US Home Diagnostics for Urinary Tract Infection Market Analysis – by Distribution Channel
8.1 Retail Pharmacies & Drug Stores
- 8.1.1 Overview
- 8.1.2 Retail Pharmacies & Drug Stores: US Home Diagnostics for Urinary Tract Infection Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Supermarkets/Hypermarkets
- 8.2.1 Overview
- 8.2.2 Supermarkets/Hypermarkets: US Home Diagnostics for Urinary Tract Infection Market – Revenue and Forecast to 2027 (US$ Million)
8.3 Online Pharmacies
- 8.3.1 Overview
- 8.3.2 Online Pharmacies : US Home Diagnostics for Urinary Tract Infection Market – Revenue and Forecast to 2027 (US$ Million)
9. US Home Diagnostics for Urinary Tract Infection Market – United States Analysis
9.1 United States
- 9.1.1 US Home Diagnostics for Urinary Tract Infection Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 9.1.1.1 US Home Diagnostics for Urinary Tract Infection Market – Revenue and
Forecast Analysis – by Country
- 9.1.1.1 United States :
US Home Diagnostics for Urinary Tract Infection Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.1.1 United States : US Home Diagnostics for Urinary Tract Infection Market Breakdown, by Form Type
- 9.1.1.1.2 United States : US Home Diagnostics for Urinary Tract Infection Market Breakdown, by Distribution Channel
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. US Home Diagnostics for Urinary Tract Infection Market Industry Landscape
11.1 Overview
11.2 Mergers and Acquisitions
11.3 Agreements, Collaborations, and Joint Ventures
11.4 New Product Launches
11.5 Expansions and Other Strategic Developments
12. Company Profiles
12.1 i-Health, Inc (AZO)
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 F. Hoffmann-La Roche AG (Roche Holding AG)
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Acon Laboratories, Inc.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Becton Dickinson and Company
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Arkray Inc.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Pathnostics
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Abbott Laboratories
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Aytu BioScience, Inc. (Innovus Pharmaceuticals, Inc)
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Teco Diagnostics
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Scanwell Health
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
13. Appendix
13.1 About Business Market Insights